NFE2L2 and metabolic dysfunction-associated steatotic liver disease: In the experimental model of NAFLD, Nrf2 is involved in liver fat metabolism-related genes and liver fatty acid metabolism; Nrf2 activation has been reported to reduce oxidative stress and prevent hepatic steatosis [56].